Lapix Therapeutics announced it raised $2.22 Million in an initial filing from an offering of $5.5 Million
Lapix Therapeutics announced it raised $2.22 Million in an initial filing from an offering of $5.5 Million
08/19/24, 1:59 PM
Location
bostonMoney raised
$2.22 million
Industry
therapeutics
biotechnology
health care
Company Info
Location
75 kneeland street
boston, massachusetts, united states
Additional Info
LAPIX Therapeutics, Inc. is a biopharmaceutical company focused on developing novel, orally bioavailable immune system restoration therapies for autoimmune diseases. The company is dedicated to transforming how medical communities treat and support patients diagnosed with serious and complex autoimmune diseases.